In 1995, the average time to a successful exit for a medical device startup was about 3 years, according to Rotational Medical CEO Martha Shadan. Now, Shadan said, it can range from 6 to 9 years and cost as much as $50 million. Shadan suggested that the increase in exit time is probably due to […]
Sunshine Heart shifts focus to Aquadex FlexFlow system
Sunshine Heart (NSDQ:SSH) said today it will realign its strategy to focus on its recently acquired Aquadex FlexFlow system, designed to filter water and salt from patients with fluid overload due to renal failure. The Eden Prairie, Minn.-based company acquired the system from Baxter for $5 million in August this year. It also said it […]
iBeat launches wearable heart monitor
iBeat said today that it launched its wearable heart monitor on Indiegogo. The campaign began this morning and features a 78% sale on the device at $99 for 100 early-bird backers. The San Francisco, Calif.-based start-up raised $1.5 million in seed funding in August to recruit “high profile talent” to expand its operations. Dr. Mehmet […]
Tackling the gender disparity in medtech
Over the course of her 30 year career in medtech, IBM Watson Health general manager Deborah DiSanzo has been a firsthand witness to the effects of gender imbalance within the industry. She started as a project manager for Apollo Computer, and after Apollo was bought by Hewlett-Packard, DiSanzo recalled there were plenty of women working beside her. “I […]
ScandiDos launches non-extrapolated radiation dose monitor
ScandiDos this week unveiled its non-extrapolated radiation dose monitor, Delta4 Synthesis, touting the accuracy of the device. The announcement was made at the 58th annual ASTRO meeting this week in Boston. The Uppsala, Sweden-based company integrated the Delta4 Phantom and Delta4 Discover into 1 system, creating the 1st and only quality assurance device that provides exact measurements, […]
Mevion touts new proton therapy tech
Mevion Medical Systems announced its latest development in proton therapy, touting improvements that could allow its Hyperscan system to treat tumors other proton therapy systems cannot. The announcement was made at the 58th annual ASTRO meeting this week in Boston. CEO Joseph Jachinowski told MassDevice.com that the Littleton, Mass.-based company’s Hyperscan system is now integrated with the Adaptive […]
Medtronic touts 1st-in-human use of Sugar.IQ with Watson ‘cognitive app’
Medtronic (NYSE:MDT) said today it launched its Sugar.IQ with Watson ‘cognitive app’ for people living with diabetes. The 1st users participating in the testing of the final release candidate will provide information about the app’s usability and function, the Fridley, Minn.-based company said. The Sugar.IQ app was developed to integrate Medtronic’s continuous glucose monitoring sensors with IBM (NYSE:IBM) Watson […]
SentreHeart closes $35m Series D for Lariat trial
SentreHeart said today that it landed a $35 million Series D round from Deerfield Management, with funds slated to support a trial evaluating its Lariat suture delivery system. The Amaze trial aims to investigate the use of Lariat for catheter-based left atrial appendage closure in patients with persistent atrial fibrillation, the Redwood City, Calif-based company […]
Elekta touts MR-imaging radiotherapy combo at ASTRO
Richard Hausmann built his career on the physics of imaging – he spent 23 years at Siemens (NYSE:SI) and 4 years at GE (NYSE:GE) developing the magnetic resonance and computerized tomography businesses before joining Elekta (STO:EKTA B) as president & CEO in June 2016. Hausmann told MassDevice.com yesterday that Elekta’s new MR-linac system, which combines MR imaging […]
Mylan clarifies $104 profit on $600 EpiPens
Mylan (NSDQ:MYL) said again today that it makes just $104 profit on its $600 EpiPen, after the Wall Street Journal reported that the company applied the statutory U.S. tax rate of 37.5% for its testimony before the Senate, according to Reuters. “Without the tax-related reduction, Mylan’s profits on the EpiPen 2-pack would be closer to […]
EIT lands investment from SHS for 3D-printed ortho implant
German private equity player SHS said it invested an undisclosed amount in Emerging Implant Technologies and its 3D-printed orthopedic implants. EIT develops 3D-printed orthopedic devices and implants, sporting a portfolio of spinal fusion cages and patient-specific implants. The Tuttlingen, Germany-based company said it plans to use the investment to expand its manufacturing capabilities internationally, including […]